Tariffs and Tensions: Trump’s Trade Gambit Targets Copper, Pharma, and Chips

In a sweeping escalation of his global trade strategy, former President Donald Trump has announced a series of aggressive tariffs aimed at reshaping U.S. economic dependencies. Speaking during a cabinet meeting, Trump revealed a 50% tariff on imported copper, a move intended to bolster domestic production of a metal vital to electric vehicles, military hardware, and infrastructure.

But copper is just the beginning. Trump also signaled plans for 200% tariffs on pharmaceuticals, with a grace period of up to 18 months for companies to adjust their supply chains. Semiconductors are next in line, as the administration eyes duties on chips to reduce reliance on foreign tech.

The announcement comes amid a flurry of tariff letters sent to 14 nations—including Japan and South Korea—who now face 25% levies starting August 1. Trump hinted that the European Union would soon receive its own tariff notice, though he praised the bloc’s “very nice” behavior in ongoing negotiations.

Market reactions were mixed. Copper futures surged over 10% following the news, while pharmaceutical stocks dipped. Analysts remain skeptical, citing the so-called “TACO trade” (Trump Always Chickens Out) as a reason for muted investor panic.

With only two trade deals finalized—UK and Vietnam—Trump’s administration faces mounting pressure to deliver on its promise of “90 deals in 90 days.” As the August 1 deadline looms, global partners scramble to negotiate, while critics warn of rising consumer costs and economic instability.